| Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | |
|---|---|---|---|---|---|
Net income | |||||
264,493 | 279,542 | 174,954 | -163,299 | 167,512 | |
Depreciation and amortization | |||||
63,778 | 60,284 | 60,248 | 68,731 | - | |
Depreciation and amortization | |||||
- | - | - | - | 61,484 | |
Impairment charges | |||||
- | - | - | 262,400 | - | |
Foreign currency transaction (gain) loss, net | |||||
-3,364 | 684 | 2,047 | -457 | -10,622 | |
Net (gain) loss on asset dispositions | |||||
-1,539 | -1,944 | -2,114 | -1,255 | -608 | |
LIFO liquidation income | |||||
190 | 204 | 754 | 297 | 569 | |
Stock issued for employee benefit plans | |||||
853 | 1,138 | 3,719 | 3,954 | 4,732 | |
Stock-based compensation expense | |||||
5,384 | 6,453 | 6,398 | 2,980 | 4,500 | |
Excess tax benefits from stock-based compensation | |||||
3,305 | 3,396 | 3,195 | 479 | 8,523 | |
Deferred income taxes | |||||
-1,363 | -10,574 | -8,756 | -8,227 | -4,264 | |
Receivables | |||||
-37,983 | 88,380 | 43,845 | -72,056 | -9,463 | |
Inventories | |||||
27,718 | 46,374 | 15,418 | -67,498 | -35,058 | |
Accounts payable and accrued liabilities | |||||
-39,746 | 88,933 | 36,705 | -89,918 | -20,570 | |
Other assets and liabilities, net | |||||
16,263 | -11,129 | 7,875 | 5,800 | -17,746 | |
Net cash provided by operating activities | |||||
288,809 | 299,811 | 202,248 | 211,311 | 277,799 | |
Capital expenditures | |||||
49,750 | 55,688 | 33,039 | 42,766 | 41,047 | |
Net cash paid in business combinations | |||||
- | 196,373 | 12,142 | 81 | 356,506 | |
Disposals of property, plant and equipment | |||||
9,027 | 3,735 | 2,681 | 1,187 | 2,236 | |
Other, net | |||||
- | - | - | 2 | -912 | |
Net cash used in investing activities | |||||
-40,723 | -248,326 | -42,500 | -41,662 | -394,405 | |
Principal payments on short-term borrowings | |||||
8,245 | 18,496 | 24,866 | 33,466 | 66,940 | |
Proceeds from short-term borrowings | |||||
8,102 | 13,371 | 26,913 | 25,018 | 64,920 | |
Principal payments on long-term debt | |||||
279,485 | 330,108 | 82,808 | 231,725 | 628,068 | |
Proceeds from long-term debt | |||||
244,037 | 447,594 | 8,034 | 52,169 | 877,130 | |
Proceeds from stock option exercises | |||||
7,180 | 7,514 | 19,565 | 3,751 | 11,099 | |
Excess tax benefits from stock-based compensation | |||||
3,305 | 3,396 | 3,195 | 479 | 8,523 | |
Purchase of treasury stock | |||||
115,516 | 132,607 | 49,400 | 867 | 100,919 | |
Debt issuance costs | |||||
- | 599 | - | 166 | 8,891 | |
Cash dividends paid | |||||
9,916 | 10,384 | 10,499 | 2,608 | - | |
Purchase of shares from noncontrolling interests | |||||
- | 18,806 | - | - | - | |
Other | |||||
-1,088 | -1,023 | -992 | -760 | -1,258 | |
Net cash used in financing activities | |||||
-151,626 | -40,148 | -110,858 | -188,175 | 155,596 | |
Effect of exchange rate changes on cash and cash equivalents | |||||
2,281 | -13,107 | -1,597 | 7,527 | -11,177 | |
Net increase in cash and cash equivalents | |||||
98,741 | -1,770 | 47,293 | -10,999 | 27,813 | |